Please wait a minute...
浙江大学学报（医学版）
浙江大学学报（医学版）  2017, Vol. 46 Issue (5): 462-467    DOI: 10.3785/j.issn.1008-9292.2017.10.02
精准影像医学专题     
胰腺癌的影像学精准诊断与评估
潘瑶, 陈洁瑜, 余日胜
浙江大学医学院附属第二医院放射科, 浙江 杭州 310009
Accurate imaging diagnosis and evaluation of pancreatic cancer
PAN Yao, CHEN Jieyu, YU Risheng
Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
 全文: PDF(922 KB)  
摘要：

胰腺癌是一种高度恶性肿瘤，手术切除是唯一可能治愈的方法。为提高胰腺癌患者的预后，胰腺癌的早期精准诊断与评估非常重要。影像学检查在胰腺癌的发现、肿瘤分期、可切除性评估等方面起重要作用，可以为胰腺癌的诊治提供可靠依据。目前常用于胰腺癌的影像学检查包括常规超声、超声内镜、PET-CT、多层螺旋CT （MDCT）以及磁共振等，不同的影像学检查具有各自的特点，其中MDCT和磁共振应用最广泛。本文对影像学在胰腺癌的精准诊断和评估中的应用研究进展进行综述。
关键词： 胰腺肿瘤/诊断;  胰腺肿瘤/外科学;  磁共振成像;  预后;  综述;  胰腺肿瘤/病理学;  肿瘤分期;  体层摄影术,螺旋计算机    
Abstract:

Pancreatic cancer is a highly malignant tumor and surgical resection is the only curative treatment option. In order to improve the prognosis of patients with pancreatic cancer, it is very important to diagnose and evaluate pancreatic cancer accurately and early. Imaging examinations play an important role in tumor detection, staging and surgical resectability evaluation, which can provide reliable evidences for diagnosis and treatment of pancreatic cancer. At present, the imaging techniques commonly used for diagnosis of pancreatic cancer include conventional ultrasound, endoscopic ultrasonography, PET-CT, multi-detector row CT (MDCT), magnetic resonance imaging (MRI), in which MDCT and MRI are the most widely used. In this article, the application and research progress of imaging in accurate diagnosis and evaluation of pancreatic cancer are reviewed.
Key words: Pancreatic neoplasms/pathology    Tomography,spiral computed    Magnetic resonance imaging    Prognosis    Pancreatic neoplasms/surgery    Review    Pancreatic neoplasms/diagnosis    Neoplasm staging
收稿日期: 2017-04-21 出版日期: 2017-10-25
CLC:  R445  
基金资助:

浙江省胰腺癌综合诊治科技创新团队计划（2013TD06）
通讯作者: 余日胜(1964-),男,博士,主任医师,博士生导师,主要从事消化系统影像学研究;E-mail:risheng-yu@zju.edu.cn;http://orcid.org/0000-0002-2428-0268     E-mail: risheng-yu@zju.edu.cn
作者简介: 潘瑶(1991-),女,硕士研究生,主要从事消化系统影像学研究;E-mail:panyao910920@163.com;http://orcid.org/0000-0001-9215-0804
服务　　
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章　　

引用本文:

潘瑶 等. 胰腺癌的影像学精准诊断与评估[J]. 浙江大学学报（医学版）, 2017, 46(5): 462-467.

PAN Yao, CHEN Jieyu, YU Risheng. Accurate imaging diagnosis and evaluation of pancreatic cancer. Journal of ZheJiang University(Medical Science), 2017, 46(5): 462-467.

链接本文:

http://www.zjujournals.com/xueshu/med/CN/10.3785/j.issn.1008-9292.2017.10.02    或    http://www.zjujournals.com/xueshu/med/CN/Y2017/V46/I5/462

[1] CONROY T, BACHET J B, AYAV A, et al. Current standards and new innovative approaches for treatment of pancreatic cancer[J]. Eur J Cancer,2016,57:10-22.
[2] HERREROS-VILLANUEVA M, GIRONELLA M, CASTELLS A, et al. Molecular markers in pancreatic cancer diagnosis[J]. Clin Chim Acta,2013,418(1):22-29.
[3] KITAJIMA K, MURAKAMI K, YAMASAKI E, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer:comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT[J]. Mol Imaging Biol,2010,12(4):452-459.
[4] FREENY P C, MARKS W M, RYAN J A, et al. Pancreatic ductal adenocarcinoma:diagnosis and staging with dynamic CT[J]. Radiology,1988,166(1 Pt 1):125-133.
[5] SCHIMA W, BA-SSALAMAH A, KOLBLINGER C, et al. Pancreatic adenocarcinoma[J]. Eur Radiol,2007,17(3):638-649.
[6] JUNG K W, KIM M H, LEE T Y, et al. Clinicopathological aspects of 542 cases of pancreatic cancer:a special emphasis on small pancreatic cancer[J]. J Korean Med Sci,2007,22 Suppl:S79-S85.
[7] PROKESCH R W, CHOW L C, BEAULIEU C F, et al. Isoattenuating pancreatic adenocarcinoma at multi-detector row CT:secondary signs[J]. Radiology,2002,224(3):764-768.
[8] YOON S H, LEE J M, CHO J Y, et al. Small (≤ 20 mm) pancreatic adenocarcinomas:analysis of enhancement patterns and secondary signs with multiphasic multidetector CT[J]. Radiology,2011,259(2):442-452.
[9] BALCI N C, SEMELKA R C. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma[J]. Eur J Radiol,2001,38(2):105-112.
[10] PARK M J, KIM Y K, CHOI S Y, et al. Preoperative detection of small pancreatic carcinoma:value of adding diffusion-weighted imaging to conventional MR imaging for improving confidence level[J]. Radiology,2014,273(2):433-443.
[11] BOUJAOUDE J. Role of endoscopic ultrasound in diagnosis and therapy of pancreatic adenocarcinoma[J]. World J Gastroenterol,2007,13(27):3662-3666.
[12] SUGIYAMA Y, FUJINAGA Y, KADOYA M, et al. Characteristic magnetic resonance features of focal autoimmune pancreatitis useful for differentiation from pancreatic cancer[J]. Jpn J Radiol,2012,30(4):296-309.
[13] ICHIKAWA T, SOU H, ARAKI T, et al. Duct-penetrating sign at MRCP:usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas[J]. Radiology,2001,221(1):107-116.
[14] KIM H J, BYUN J H, PARK S H, et al. Focal fatty replacement of the pancreas:usefulness of chemical shift MRI[J]. AJR Am J Roentgenol,2007,188(2):429-432.
[15] ISSEROW J A, SIEGELMAN E S, MAMMONE J. Focal fatty infiltration of the pancreas:MR characterization with chemical shift imaging[J]. AJR Am J Roentgenol,1999,173(5):1263-1265.
[16] TO'O K J, RAMAN S S, YU N C, et al. Pancreatic and peripancreatic diseases mimicking primary pancreatic neoplasia[J]. Radiographics,2005,25(4):949-965.
[17] KIMURA Y, KIKUYAMA M, KODAMA Y. Acute pancreatitis as a possible indicator of pancreatic cancer:the importance of mass detection[J]. Intern Med,2015,54(17):2109-2114.
[18] MENG Z, ZHANG X, ZHENG Q, et al. Acute pancreatitis as an early indicator of pancreatic head carcinoma[J]. Hepatogastroenterology,2014,61(133):1201-1206.
[19] SIEGEL R, MA J, ZOU Z, et al. Cancer statistics, 2014[J]. CA Cancer J Clin,2014,64(1):9-29.
[20] LOYER E M, DAVID C L, DUBROW R A, et al. Vascular involvement in pancreatic adenocarcinoma:reassessment by thin-section CT[J]. Abdom Imaging,1996,21(3):202-206.
[21] LU D S, REBER H A, KRASNY R M, et al. Local staging of pancreatic cancer:criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT[J]. AJR Am J Roentgenol,1997,168(6):1439-1443.
[22] LI H, ZENG M S, ZHOU K R, et al. Pancreatic adenocarcinoma:the different CT criteria for peripancreatic major arterial and venous invasion[J]. J Comput Assist Tomogr,2005,29(2):170-175.
[23] KLAUSS M, MOHR A, VON TENGG-KOBLIGK H, et al. A new invasion score for determining the resectability of pancreatic carcinomas with contrast-enhanced multidetector computed tomography[J]. Pancreatology,2008,8(2):204-210.
[24] MARINELLI T, FILIPPONE A, TAVANO F, et al. A tumour score with multidetector spiral CT for venous infiltration in pancreatic cancer:influence on borderline resectable[J]. Radiol Med,2014,119(5):334-342.
[25] BIPAT S, PHOA S S, VAN DELDEN O M, et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma:a meta-analysis[J]. J Comput Assist Tomogr,2005,29(4):438-445.
[26] FERRONE C R, MARCHEGIANI G, HONG T S, et al. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer[J]. Ann Surg,2015,261(1):12-17.
[27] KATZ M H, FLEMING J B, BHOSALE P, et al. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators[J]. Cancer,2012,118(23):5749-5756.
[28] CASSINOTTO C, MOURIES A, LAFOURCADE J P, et al. Locally advanced pancreatic adenocarcinoma:reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy[J]. Radiology,2014,273(1):108-116.
[29] CASSINOTTO C, CORTADE J, BELLEANNEE G, et al. An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment[J]. Eur J Radiol,2013,82(4):589-593.
[30] THOMASSET S C, LOBO D N. Pancreatic cancer[J]. Surgery(Oxford),2010,28(5):198-204.
[31] IMAI H, DOI R, KANAZAWA H, et al. Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer[J]. Int J Clin Oncol,2010,15(3):294-300.
[32] GOLDER W A. Lymph node diagnosis in oncologic imaging:a dilemma still waiting to be solved[J]. Onkologie,2004,27(2):194-199.
[33] I·NAL A, KOS F T, ALGIN E, et al. Prognostic factors for gemcitabine-refractory patients with advanced pancreatic cancer:a retrospective analysis of a multicentre study (anatolian society of Medical Oncology)[J]. Contemp Oncol (Pozn),2015,19(2):125-129.
[34] BRUEGEL M, HOLZAPFEL K, GAA J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique[J]. Eur Radiol,2008,18(3):477-485.
[35] MOTOSUGI U I T, MORISAKA H, SOU H, et al. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging_comparison with contrast-enhanced multi-detector row CT[J]. Radiology,2011,260:446-453.
[36] LEE K H, LEE J M, PARK J H, et al. MR imaging in patients with suspected liver metastases:value of liver-specific contrast agent gadoxetic acid[J]. Korean J Radiol,2013,14(6):894-904.
[1] 许晶晶 等. 影像学在肿瘤精准医疗时代的机遇和挑战[J]. 浙江大学学报（医学版）, 2017, 46(5): 455-461.
[2] 潘静颖 等. PET-CT与乳腺癌分子病理分型、治疗反应及预后的相关性研究进展[J]. 浙江大学学报（医学版）, 2017, 46(5): 473-480.
[3] 杨荣 等. Molday IONTM EverGreen标记大鼠骨髓内皮祖细胞及体外磁共振成像研究[J]. 浙江大学学报（医学版）, 2017, 46(5): 481-486.
[4] 张思影 等. CT和磁共振参数反应图在肿瘤精准疗效评估中的研究进展[J]. 浙江大学学报（医学版）, 2017, 46(5): 468-472.
[5] 李爱静 等. 动态增强磁共振成像参照物模型定量参数与乳腺癌预后因素及分子病理分型的关系[J]. 浙江大学学报（医学版）, 2017, 46(5): 505-510.
[6] 胡静 等. 记忆T细胞在行放射治疗的非小细胞肺癌患者中的表达及其预后预测价值[J]. 浙江大学学报（医学版）, 2017, 46(5): 523-528.
[7] 裴磊 等. 磁共振平扫T1加权像脑内核团高信号与钆对比剂注射次数的相关性[J]. 浙江大学学报（医学版）, 2017, 46(5): 487-491.
[8] 董飞 等. 磁共振成像强化信号特征预测胶质母细胞瘤EGFR基因扩增状态的影像组学研究[J]. 浙江大学学报（医学版）, 2017, 46(5): 492-497.
[9] 王苏波 等. 动态对比增强磁共振药代动力学模型在鉴别富细胞型子宫平滑肌瘤中的应用[J]. 浙江大学学报（医学版）, 2017, 46(5): 498-504.
[10] 王梦嫣 等. 耶氏肺孢子菌对磺胺类药物耐药相关基因突变的研究进展[J]. 浙江大学学报（医学版）, 2017, 46(5): 563-569.
[11] 张美霞 等. 静脉溶栓获益的最大梗死体积阈值与急性缺血性卒中患者发病时间的关系[J]. 浙江大学学报（医学版）, 2017, 46(4): 384-389.
[12] 李艳蝶 等. NLRP3炎症小体与儿童自身炎症性疾病研究进展[J]. 浙江大学学报（医学版）, 2017, 46(4): 449-453.
[13] 赖针珍 等. 动态CT血管造影评估急性基底动脉闭塞患者侧支血流与再灌注治疗预后的关系[J]. 浙江大学学报（医学版）, 2017, 46(4): 371-376.
[14] 冯学问 等. 急性缺血性卒中患者血管内治疗后应用替罗非班的安全性及预后分析[J]. 浙江大学学报（医学版）, 2017, 46(4): 397-404.
[15] 王庆松 等. 基于CT灌注成像的侧支评分预测急性前循环大血管闭塞患者动脉取栓治疗预后的价值[J]. 浙江大学学报（医学版）, 2017, 46(4): 377-383.